Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Screening Clinical Trials for Cervical Cancer

Review the cervical cancer screening clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-16 of 16

Effectiveness of Screening Women with Lower Genital Tract Neoplasia or Cancers for Anal Cancer Precursors
Status: Active
Location: 4 locations
Optimization of Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People Living with HIV in Mexico and Puerto Rico
Status: Active
Location: 2 locations
A Novel Community-Based Strategy (Self-Sampling HPV Testing) to Improve Access to Cervical Cancer Screening in the Rio Grande Valley of Texas, the Prevencion en sus Manos Trial
Status: Active
Location: 2 locations
Patient Navigation Services for the Improvement of Cancer Screening among Underserved Neighborhoods in New York City, NYC CONNECT Trial
Status: Active
Location: 2 locations
Self-Sampling for HPV in the Emergency Department to Increase Cervical Cancer Screening
Status: Active
Location: University of Rochester, Rochester, New York
mSaada Mobile Health Tool for the Improvement of Cervical Cancer Screening in Western Kenya
Status: Active
Location: See ClinicalTrials.gov
Testing the Accuracy of a Self-Collected Pap Smear Versus Healthcare Provider-Collected Pap Smear for Cervical Cancer Screening
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Assessment of New Technologies for the Screening and Diagnosis of Cervical Cancer in Mozambique
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Multi-Level Intervention for Improving Screening Rates of Breast, Cervical and Colorectal Cancer in Women in Low-Income Communities
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
High Risk HPV Testing and Self-sampling in Clinical Settings for Improving Access to Cervical Cancer Screening in Safety Net Health Systems
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
The Cancer Tracking System to Improve Cervical Cancer Screening, Referral and Treatment of Women in Kenya, The CATSystem Trial
Status: Approved
Location: University of Kansas Cancer Center, Kansas City, Kansas
Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
Status: Approved
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Status: Active
Location: 17 locations
Prevention and Early Detection of Cervical Cancer through Self-Administered Screening
Status: Active
Location: University of California San Francisco, San Francisco, California
Plasma Circulating Tumor HPVDNA and Transrenal HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance following Definitive Treatment
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas